| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |